Regulatory Affairs, Quality Systems, Policy, and Ethics: AUTOLOGOUS CAR T CELL PRODUCT FROM COVID-19-POSITIVE PATIENT: MANUFACTURING AND REGULATORY CONSIDERATIONS

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) England), 2022-05, Vol.24 (5), p.S191
Main Authors: Sikder, D., Senechal, B., Wang, X., Geyer, M., Riviere, I.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1465-3249
DOI:10.1016/S1465-3249(22)00490-X